32.54

0.46% -0.153

Atricure Inc (ATRC)

Overview News Price History Option Chain Financials Discussions Forecast

Atricure Inc stock is traded at $32.54, with a volume of 174.46K. It is down -0.46% in the last 24 hours and down -17.81% over the past month. AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

Previous Close:

$32.69

Open:

$32.87

24h Volume:

174.46K

Relative Volume:

0.35

Market Cap:

$1.62B

Revenue:

$447.57M

Net Income/Loss:

$-38.92M

P/E Ratio:

-39.20

EPS:

-0.83

Net Cash Flow:

$-1.15M

1W Performance:

-10.23%

1M Performance:

-17.81%

6M Performance:

+15.35%

1Y Performance:

-4.27%

1-Day Range:

$32.47

$33.69

1-Week Range:

$32.49

$36.15

52-Week Range:

$18.94

$43.11

Atricure Inc Stock (ATRC) Company Profile

Name

Atricure Inc

Sector

Healthcare (1172)

Industry

Medical Instruments & Supplies (62)

Phone

513-755-4100

Address

7555 INNOVATION WAY, MASON, OH

Employee

1,200

Twitter

@AtriCure

Next Earnings Date

2024-10-29

Latest SEC Filings

ATRC's Discussions on Twitter

Compare ATRC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ATRC Atricure Inc	32.50	1.62B	447.57M	-38.92M	-1.15M	-0.83
ISRG Intuitive Surgical Inc	479.38	171.84B	8.35B	2.32B	1.30B	6.41
BDX Becton Dickinson Co	224.09	64.03B	20.64B	1.73B	2.94B	6.02
ALC Alcon Inc	87.23	43.91B	9.91B	1.02B	665.00M	2.05
RMD Resmed Inc	218.93	32.15B	4.93B	1.25B	1.38B	8.47
BAX Baxter International Inc	34.75	17.46B	17.28B	108.00M	391.00M	0.20

Atricure Inc Stock (ATRC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-17-24	Resumed	JP Morgan	Overweight
Apr-23-24	Upgrade	Oppenheimer	Perform → Outperform
Oct-23-23	Initiated	JMP Securities	Mkt Outperform
Sep-29-23	Initiated	UBS	Buy
Aug-05-21	Downgrade	Oppenheimer	Outperform → Perform
Dec-18-20	Reiterated	Needham	Buy
Nov-06-20	Reiterated	Needham	Buy
Apr-07-20	Initiated	Oppenheimer	Outperform
Feb-06-20	Initiated	BTIG Research	Buy
Jan-24-20	Reiterated	Needham	Buy
Aug-13-19	Downgrade	Northland Capital	Outperform → Market Perform
Apr-12-19	Initiated	JP Morgan	Overweight
Oct-04-18	Reiterated	Needham	Buy
Aug-02-18	Reiterated	Needham	Buy
Aug-02-18	Reiterated	Stifel	Buy
Jun-18-18	Reiterated	Needham	Buy
Apr-27-18	Reiterated	Needham	Buy
Jan-16-18	Reiterated	Needham	Buy
Nov-02-17	Reiterated	Needham	Buy
Jul-28-17	Reiterated	Needham	Buy
May-30-17	Resumed	Piper Jaffray	Overweight
Jun-30-16	Resumed	JMP Securities	Mkt Outperform
Oct-28-15	Reiterated	Needham	Buy
Oct-06-15	Reiterated	Canaccord Genuity	Buy
Oct-06-15	Reiterated	Needham	Buy

View All

Atricure Inc Stock (ATRC) Latest News

Mar 12, 2025

AtriCure Investor Day: New Product Pipeline and Financial Targets Coming March 2025 - StockTitan

Mar 12, 2025

Mar 09, 2025

AtriCure, Inc. to Host Earnings Call - ACCESS Newswire

Mar 09, 2025

AtriCure Independent Director Karen Prange Sells 25% Of Holding - Simply Wall St

Mar 09, 2025

Mar 08, 2025

(ATRC) Long Term Investment Analysis - Stock Traders Daily

Mar 08, 2025

AtriCure (NASDAQ:ATRC) Stock Price Down 6% Following Insider Selling - Defense World

Mar 08, 2025

Atricure director Karen Prange sells $232,531 in stock By Investing.com - Investing.com Canada

Mar 08, 2025

Mar 07, 2025

Atricure Director Makes a Significant Stock Sale! - TipRanks

Mar 07, 2025

Insider Sell: Karen Prange Sells 6,100 Shares of AtriCure Inc (A - GuruFocus.com

Mar 07, 2025

Atricure director Karen Prange sells $232,531 in stock - Investing.com India

Mar 07, 2025

Mar 06, 2025

Insider Buying: Chief Technical Officer Salvatore Privitera Acqu - GuruFocus.com

Mar 06, 2025

Mar 03, 2025

Rhumbline Advisers Has $2.41 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC) - Defense World

Mar 03, 2025

Feb 28, 2025

AtriCure, Inc. (NASDAQ:ATRC) Q4 2024 Earnings Call Transcript - MSN

Feb 28, 2025

Feb 21, 2025

26,035 Shares in AtriCure, Inc. (NASDAQ:ATRC) Acquired by AlphaCentric Advisors LLC - MarketBeat

Feb 21, 2025

HighMark Wealth Management LLC Has $2.56 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat

Feb 21, 2025

Feb 20, 2025

Short Interest in AtriCure, Inc. (NASDAQ:ATRC) Declines By 20.4% - MarketBeat

Feb 20, 2025

Feb 18, 2025

Stifel Nicolaus Raises AtriCure (NASDAQ:ATRC) Price Target to $48.00 - MarketBeat

Feb 18, 2025

AtriCure (NASDAQ:ATRC) Price Target Raised to $45.00 at Oppenheimer - MarketBeat

Feb 18, 2025

AtriCure (NASDAQ:ATRC) Stock Price Down 5.8%Here's What Happened - MarketBeat

Feb 18, 2025

AtriCure (NASDAQ:ATRC) Stock Price Expected to Rise, Piper Sandler Analyst Says - MarketBeat

Feb 18, 2025

Feb 17, 2025

Canaccord Genuity Group Forecasts Strong Price Appreciation for AtriCure (NASDAQ:ATRC) Stock - MarketBeat

Feb 17, 2025

Feb 16, 2025

AtriCure targets $517M-$527M revenue in 2025 with new product launches and international growth - MSN

Feb 16, 2025

Feb 15, 2025

Exploring Analyst Estimates for AtriCure (ATRC) Q4 Earnings, Beyond Revenue and EPS - MSN

Feb 15, 2025

(ATRC) Technical Pivots with Risk Controls - Stock Traders Daily

Feb 15, 2025

AtriCure (NASDAQ:ATRC) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World

Feb 15, 2025

AtriCure (NASDAQ:ATRC) Price Target Raised to $51.00 at JPMorgan Chase & Co. - MarketBeat

Feb 15, 2025

Feb 14, 2025

Atricure Files For Mixed Shelf; Size Not DisclosedSEC Filing -February 14, 2025 at 03:53 pm EST - Marketscreener.com

Feb 14, 2025

AtriCure (ATRC) Upgraded to Buy: Here's What You Should Know - MSN

Feb 14, 2025